Fungal-derived immune modulating molecules

Area of Science:

• Immunology
• Mycology
• Pathogenesis

Background:

• Invasive fungal infections pose a growing clinical challenge, necessitating novel therapeutic strategies.
• Early host-pathogen interactions are key to developing new antifungal drugs and vaccines.
• Fungi engage the innate immune system through specific molecular signatures (PAMPs) binding to host receptors (PRRs).

Purpose of the Study:

• To summarize recent advances in understanding fungal PAMP-PRR interactions in the context of fungal infection pathogenesis.
• To explore the potential of targeting these interactions for therapeutic development.

Main Methods:

• Review of current literature on fungal PAMPs (mannoproteins, beta-glucans, etc.) and their cognate PRRs (Toll-like receptors, C-lectin-like receptors).
• Analysis of in vitro studies dissecting phagocyte responses to isolated fungal PAMPs.
• Discussion of the implications of these interactions for host immune responses and pathogenesis.

Main Results:

• Fungal PAMPs, primarily cell wall carbohydrates, bind to specific PRRs on mononuclear phagocytes.
• This binding initiates signaling cascades, leading to cytokine release and linking innate and adaptive immunity.
• In vitro studies reveal mechanisms for tailoring immune responses but in vivo roles remain complex.

Conclusions:

• Understanding fungal PAMP-PRR interactions is crucial for developing new therapies against invasive fungal infections.
• Further research is needed to elucidate the in vivo significance of these complex molecular interactions.
• Targeting PAMP-PRR pathways offers a promising avenue for novel antifungal drug and vaccine development.